Re: First-in-Human Safety, Imaging, and Dosimetry of a Carbonic Anhydrase IX-Targeting Peptide, [68Ga]Ga-DPI-4452, in Patients with Clear Cell Renal Cell Carcinoma

Re: First-in-Human Safety, Imaging, and Dosimetry of a Carbonic Anhydrase IX-Targeting Peptide, [⁶⁸Ga]Ga-DPI-4452, in Patients with Clear Cell Renal Cell Carcinoma

Eur Urol. 2024 Apr 16:S0302-2838(24)02256-5. doi: 10.1016/j.eururo.2024.03.028. Online ahead of print.

¹ Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia.
² Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Department of Urology, Santiago Clinic Hospital, Santiago de Compostela, Spain.
³ Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Medical School Hamburg, Hamburg, Germany.
⁴ Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Department of Urology, Royal Melbourne Hospital, Melbourne, Australia.
⁵ Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. Electronic address: declan.murphy@petermac.org.

No abstract available